ArticleCancer management and research2019
Optimal management of thymic malignancies: current perspectives.
Article in Cancer management and research, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02724696 (French National Observatory of Patients With Thymic Epithelial Tumor), which is not on this map. Cited by 17 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
French National Observatory of Patients With Thymic Epithelial Tumor
Who cites it
17 citing papers in PubMed.
- A hybrid approach via video-assisted thoracoscopic surgery and limited sternal incision for resection of invasive thymoma with superior vena cava prosthetic replacement: a case report.Journal of cardiothoracic surgery · 2026Article
- Evolving paradigms in thymoma surgery and multidisciplinary care: a narrative review.Mediastinum (Hong Kong, China) · 2026Review
- Computer tomography-based three-dimensional reconstruction of an extended AB-thymoma: a case report.Journal of surgical case reports · 2025Article
- Artificial intelligence for diagnosis and prognosis of thymic epithelial tumors: a systematic review.Mediastinum (Hong Kong, China) · 2025Review
- Article
- Clinical Outcomes of Thymic Carcinoma: The Role of Radiotherapy Combined with Multimodal Treatments.Cancers · 2023Article
- Review
- Diagnostic value of apparent diffusion coefficient in predicting pathological T stage in patients with thymic epithelial tumor.Cancer imaging : the official publication of the International Cancer Imaging Society · 2022Article
- Thymic Carcinomas-A Concise Multidisciplinary Update on Recent Developments From the Thymic Carcinoma Working Group of the International Thymic Malignancy Interest Group.Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer · 2022Review
- The Never-Ending History of Octreotide in Thymic Tumors: A Vintage or A Contemporary Drug?Cancers · 2022Review
- Development of a competing risk nomogram for the prediction of cause-specific mortality in patients with thymoma: a population-based analysis.Journal of thoracic disease · 2021Article
- Radiotherapy for thymic epithelial tumours: a review.Translational lung cancer research · 2021Review
- Surgical management of thymic epithelial tumors.Surgery today · 2021Review
- Co-existent Epicardial Paraganglioma and Anterior Mediastinal Thymoma.Journal of radiology case reports · 2020Article
- Rarity among the rare-large and invasive thymoma, a case report and review.Journal of community hospital internal medicine perspectives · 2020Article
- Value of metabolic parameters in distinguishing primary mediastinal lymphomas from thymic epithelial tumors.Cancer biology & medicine · 2020Article
- Thymic Epithelial Tumors as a Model of Networking: Development of a Synergistic Strategy for Clinical and Translational Research Purposes.Frontiers in oncology · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Thymic epithelial tumors (TETs) belong to orphan oncology. The incidence of TETs is about 1.3-3.2 cases per million worldwide. Following pathology, evolution and prognosis are variable. The World Health Organization classification distinguishes thymomas and thymic carcinomas. TETs are composed of thymic epithelial tumoral cells and normal lymphocytes. The mean age at diagnosis is 50-60 years-old. There are no identified risk factors. TETs are frequently associated with paraneoplastic syndromes as myasthenia gravis. The complete R
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.